A detailed history of Ra Capital Management, L.P. transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Ra Capital Management, L.P. holds 2,253,000 shares of BCYC stock, worth $51.2 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares
2,253,000
Holding current value
$51.2 Million
% of portfolio
0.69%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$20.02 - $24.69 $45.1 Million - $55.6 Million
2,253,000 New
2,253,000 $45.6 Million
Q4 2023

Feb 14, 2024

BUY
$13.29 - $22.2 $10.6 Million - $17.8 Million
800,000 New
800,000 $14.5 Million
Q3 2023

Nov 14, 2023

BUY
$19.9 - $26.25 $15.9 Million - $21 Million
800,000 New
800,000 $16.1 Million

Others Institutions Holding BCYC

About BICYCLE THERAPEUTICS plc


  • Ticker BCYC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,676,100
  • Market Cap $674M
  • Description
  • Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...
More about BCYC
Track This Portfolio

Track Ra Capital Management, L.P. Portfolio

Follow Ra Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Ra Capital Management, L.P. with notifications on news.